The influence of concomitant antidepressant and antipsychotic medication on antidepressant effect and seizure duration of electroconvulsive therapy

A significant proportion of patients with a depressive disorder show resistance to pharmacological and psychotherapeutic antidepressant treatments. Electroconvulsive therapy (ECT) is still one of the most effective treatment methods, especially in the acute phase. In everyday clinical practice, this...

Full description

Saved in:
Bibliographic Details
Published in:Frontiers in psychiatry 2024-03, Vol.15, p.1341508-1341508
Main Authors: Mohamad, Sara, Trumm, Samuel, Treskatsch, Sascha, Drevs, Alisha, Bajbouj, Malek, Wiedemann, Leonardo
Format: Article
Language:English
Subjects:
antidepressants
antipsychotics
ECT
electroconvulsive therapy
Psychiatry
seizure duration
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites cdi_FETCH-LOGICAL-c420t-99007768644a260fd8456d9c20321fc9da34be7e4f00ada1fb719db815840f6c3
container_end_page 1341508
container_issue
container_start_page 1341508
container_title Frontiers in psychiatry
container_volume 15
creator Mohamad, Sara
Trumm, Samuel
Treskatsch, Sascha
Drevs, Alisha
Bajbouj, Malek
Wiedemann, Leonardo
description A significant proportion of patients with a depressive disorder show resistance to pharmacological and psychotherapeutic antidepressant treatments. Electroconvulsive therapy (ECT) is still one of the most effective treatment methods, especially in the acute phase. In everyday clinical practice, this usually accompanies pharmacological treatment. It has been shown that pharmacological treatment following acute ECT treatment reduces the rate of relapses. However, the effect of various antidepressants (ADs) and antipsychotics (APs) on the effect during the course of ECT has rarely been investigated. In this retrospective chart review study, the data of 104 depressive patients treated with ECT were examined. We analyzed the influence of concomitant administration of AD and AP or no psychotropic medication on the effect of ECT using the Montgomery-Åsberg Depression Rating Scale (MADRS). We further analyzed the influence of the ADs Bupropion, Venlafaxine, and Sertraline or no AD and the influence of augmentation with Aripiprazole or Quetiapine or Olanzapine. Psychotropic medication did not have an impact on antidepressant efficacy of ECT as measured with the MADRS scores. In addition, the comparison between the antidepressant or antipsychotic medications themselves did not show any significant difference. However, we found a significantly different seizure duration depending on the antidepressant substance that patients received during ECT ( = .008). ECT treatment itself led to a highly significant reduction of 13.3 points in the MADRS (
doi_str_mv 10.3389/fpsyt.2024.1341508
format article
fullrecord <record><control><sourceid>proquest_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_6d20a0d18f4244b89a360843ecfa920d</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><doaj_id>oai_doaj_org_article_6d20a0d18f4244b89a360843ecfa920d</doaj_id><sourcerecordid>3031130780</sourcerecordid><originalsourceid>FETCH-LOGICAL-c420t-99007768644a260fd8456d9c20321fc9da34be7e4f00ada1fb719db815840f6c3</originalsourceid><addsrcrecordid>eNpdUk1v3CAQtaJWSZTmD_RQ-djLbocPYzhVVdSPSJFySc8Iw5Al8hoX7JW2fyN_uGS9jZIg0MDMe28Avar6SGDNmFRf_Jj305oC5WvCOGlAnlTnRAi-AsHh3Yv9WXWZ8wOUwZRiojmtzphsBAPanFePdxusw-D7GQeLdfS1jYON2zCZYarLCg7HhDkvR3dIldZ2E6dg6y26YM0U4lCX-QaO3qNdWBnD3zlh7eZ0RPsa-1JNsfTbzX0OO6ynDSYz7j9U773pM14e40X1-8f3u6tfq5vbn9dX325WllOYVkoBtK2QgnNDBXgneSOcshQYJd4qZxjvsEXuAYwzxHctUa6TpJEcvLDsorpedF00D3pMYWvSXkcT9CER0702qbyyRy0cBQOOSM8p551UhgmQnKH1RlFwRevrojXOXfkUi8OUTP9K9HVlCBt9H3eagJJUKVIUPh8VUvwzY570NmSLfW8GjHPWDBghDFoJBUoXqE0x54T-uQ8B_eQOfXCHfnKHPrqjkD69vOEz5b8X2D-f8LvO</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3031130780</pqid></control><display><type>article</type><title>The influence of concomitant antidepressant and antipsychotic medication on antidepressant effect and seizure duration of electroconvulsive therapy</title><source>Open Access: PubMed Central</source><creator>Mohamad, Sara ; Trumm, Samuel ; Treskatsch, Sascha ; Drevs, Alisha ; Bajbouj, Malek ; Wiedemann, Leonardo</creator><creatorcontrib>Mohamad, Sara ; Trumm, Samuel ; Treskatsch, Sascha ; Drevs, Alisha ; Bajbouj, Malek ; Wiedemann, Leonardo</creatorcontrib><description>A significant proportion of patients with a depressive disorder show resistance to pharmacological and psychotherapeutic antidepressant treatments. Electroconvulsive therapy (ECT) is still one of the most effective treatment methods, especially in the acute phase. In everyday clinical practice, this usually accompanies pharmacological treatment. It has been shown that pharmacological treatment following acute ECT treatment reduces the rate of relapses. However, the effect of various antidepressants (ADs) and antipsychotics (APs) on the effect during the course of ECT has rarely been investigated. In this retrospective chart review study, the data of 104 depressive patients treated with ECT were examined. We analyzed the influence of concomitant administration of AD and AP or no psychotropic medication on the effect of ECT using the Montgomery-Åsberg Depression Rating Scale (MADRS). We further analyzed the influence of the ADs Bupropion, Venlafaxine, and Sertraline or no AD and the influence of augmentation with Aripiprazole or Quetiapine or Olanzapine. Psychotropic medication did not have an impact on antidepressant efficacy of ECT as measured with the MADRS scores. In addition, the comparison between the antidepressant or antipsychotic medications themselves did not show any significant difference. However, we found a significantly different seizure duration depending on the antidepressant substance that patients received during ECT ( = .008). ECT treatment itself led to a highly significant reduction of 13.3 points in the MADRS ( &lt;.001). Taken together, our study underlines that concomitant psychotropic medication while doing electroconvulsive therapy does not bare the risk of prolonged seizure duration or does it reduce the effectiveness of ECT. To the best of our knowledge, this study is the first to examine the effect of treatment with antidepressants in combination with antipsychotics while doing ECT. In light of our results, this combination therapy is safe and effective. Bearing in mind the delay in onset of antidepressant action of medication and the importance of antidepressant medication for relapse prevention, this study further supports the recommendation that psychotropic medication should be given in adjunction to ECT.</description><identifier>ISSN: 1664-0640</identifier><identifier>EISSN: 1664-0640</identifier><identifier>DOI: 10.3389/fpsyt.2024.1341508</identifier><identifier>PMID: 38563025</identifier><language>eng</language><publisher>Switzerland: Frontiers Media S.A</publisher><subject>antidepressants ; antipsychotics ; ECT ; electroconvulsive therapy ; Psychiatry ; seizure duration</subject><ispartof>Frontiers in psychiatry, 2024-03, Vol.15, p.1341508-1341508</ispartof><rights>Copyright © 2024 Mohamad, Trumm, Treskatsch, Drevs, Bajbouj and Wiedemann.</rights><rights>Copyright © 2024 Mohamad, Trumm, Treskatsch, Drevs, Bajbouj and Wiedemann 2024 Mohamad, Trumm, Treskatsch, Drevs, Bajbouj and Wiedemann</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c420t-99007768644a260fd8456d9c20321fc9da34be7e4f00ada1fb719db815840f6c3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC10982991/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC10982991/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,27924,27925,53791,53793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/38563025$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Mohamad, Sara</creatorcontrib><creatorcontrib>Trumm, Samuel</creatorcontrib><creatorcontrib>Treskatsch, Sascha</creatorcontrib><creatorcontrib>Drevs, Alisha</creatorcontrib><creatorcontrib>Bajbouj, Malek</creatorcontrib><creatorcontrib>Wiedemann, Leonardo</creatorcontrib><title>The influence of concomitant antidepressant and antipsychotic medication on antidepressant effect and seizure duration of electroconvulsive therapy</title><title>Frontiers in psychiatry</title><addtitle>Front Psychiatry</addtitle><description>A significant proportion of patients with a depressive disorder show resistance to pharmacological and psychotherapeutic antidepressant treatments. Electroconvulsive therapy (ECT) is still one of the most effective treatment methods, especially in the acute phase. In everyday clinical practice, this usually accompanies pharmacological treatment. It has been shown that pharmacological treatment following acute ECT treatment reduces the rate of relapses. However, the effect of various antidepressants (ADs) and antipsychotics (APs) on the effect during the course of ECT has rarely been investigated. In this retrospective chart review study, the data of 104 depressive patients treated with ECT were examined. We analyzed the influence of concomitant administration of AD and AP or no psychotropic medication on the effect of ECT using the Montgomery-Åsberg Depression Rating Scale (MADRS). We further analyzed the influence of the ADs Bupropion, Venlafaxine, and Sertraline or no AD and the influence of augmentation with Aripiprazole or Quetiapine or Olanzapine. Psychotropic medication did not have an impact on antidepressant efficacy of ECT as measured with the MADRS scores. In addition, the comparison between the antidepressant or antipsychotic medications themselves did not show any significant difference. However, we found a significantly different seizure duration depending on the antidepressant substance that patients received during ECT ( = .008). ECT treatment itself led to a highly significant reduction of 13.3 points in the MADRS ( &lt;.001). Taken together, our study underlines that concomitant psychotropic medication while doing electroconvulsive therapy does not bare the risk of prolonged seizure duration or does it reduce the effectiveness of ECT. To the best of our knowledge, this study is the first to examine the effect of treatment with antidepressants in combination with antipsychotics while doing ECT. In light of our results, this combination therapy is safe and effective. Bearing in mind the delay in onset of antidepressant action of medication and the importance of antidepressant medication for relapse prevention, this study further supports the recommendation that psychotropic medication should be given in adjunction to ECT.</description><subject>antidepressants</subject><subject>antipsychotics</subject><subject>ECT</subject><subject>electroconvulsive therapy</subject><subject>Psychiatry</subject><subject>seizure duration</subject><issn>1664-0640</issn><issn>1664-0640</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><sourceid>DOA</sourceid><recordid>eNpdUk1v3CAQtaJWSZTmD_RQ-djLbocPYzhVVdSPSJFySc8Iw5Al8hoX7JW2fyN_uGS9jZIg0MDMe28Avar6SGDNmFRf_Jj305oC5WvCOGlAnlTnRAi-AsHh3Yv9WXWZ8wOUwZRiojmtzphsBAPanFePdxusw-D7GQeLdfS1jYON2zCZYarLCg7HhDkvR3dIldZ2E6dg6y26YM0U4lCX-QaO3qNdWBnD3zlh7eZ0RPsa-1JNsfTbzX0OO6ynDSYz7j9U773pM14e40X1-8f3u6tfq5vbn9dX325WllOYVkoBtK2QgnNDBXgneSOcshQYJd4qZxjvsEXuAYwzxHctUa6TpJEcvLDsorpedF00D3pMYWvSXkcT9CER0702qbyyRy0cBQOOSM8p551UhgmQnKH1RlFwRevrojXOXfkUi8OUTP9K9HVlCBt9H3eagJJUKVIUPh8VUvwzY570NmSLfW8GjHPWDBghDFoJBUoXqE0x54T-uQ8B_eQOfXCHfnKHPrqjkD69vOEz5b8X2D-f8LvO</recordid><startdate>20240318</startdate><enddate>20240318</enddate><creator>Mohamad, Sara</creator><creator>Trumm, Samuel</creator><creator>Treskatsch, Sascha</creator><creator>Drevs, Alisha</creator><creator>Bajbouj, Malek</creator><creator>Wiedemann, Leonardo</creator><general>Frontiers Media S.A</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope></search><sort><creationdate>20240318</creationdate><title>The influence of concomitant antidepressant and antipsychotic medication on antidepressant effect and seizure duration of electroconvulsive therapy</title><author>Mohamad, Sara ; Trumm, Samuel ; Treskatsch, Sascha ; Drevs, Alisha ; Bajbouj, Malek ; Wiedemann, Leonardo</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c420t-99007768644a260fd8456d9c20321fc9da34be7e4f00ada1fb719db815840f6c3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>antidepressants</topic><topic>antipsychotics</topic><topic>ECT</topic><topic>electroconvulsive therapy</topic><topic>Psychiatry</topic><topic>seizure duration</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Mohamad, Sara</creatorcontrib><creatorcontrib>Trumm, Samuel</creatorcontrib><creatorcontrib>Treskatsch, Sascha</creatorcontrib><creatorcontrib>Drevs, Alisha</creatorcontrib><creatorcontrib>Bajbouj, Malek</creatorcontrib><creatorcontrib>Wiedemann, Leonardo</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>Open Access: DOAJ - Directory of Open Access Journals</collection><jtitle>Frontiers in psychiatry</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Mohamad, Sara</au><au>Trumm, Samuel</au><au>Treskatsch, Sascha</au><au>Drevs, Alisha</au><au>Bajbouj, Malek</au><au>Wiedemann, Leonardo</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The influence of concomitant antidepressant and antipsychotic medication on antidepressant effect and seizure duration of electroconvulsive therapy</atitle><jtitle>Frontiers in psychiatry</jtitle><addtitle>Front Psychiatry</addtitle><date>2024-03-18</date><risdate>2024</risdate><volume>15</volume><spage>1341508</spage><epage>1341508</epage><pages>1341508-1341508</pages><issn>1664-0640</issn><eissn>1664-0640</eissn><abstract>A significant proportion of patients with a depressive disorder show resistance to pharmacological and psychotherapeutic antidepressant treatments. Electroconvulsive therapy (ECT) is still one of the most effective treatment methods, especially in the acute phase. In everyday clinical practice, this usually accompanies pharmacological treatment. It has been shown that pharmacological treatment following acute ECT treatment reduces the rate of relapses. However, the effect of various antidepressants (ADs) and antipsychotics (APs) on the effect during the course of ECT has rarely been investigated. In this retrospective chart review study, the data of 104 depressive patients treated with ECT were examined. We analyzed the influence of concomitant administration of AD and AP or no psychotropic medication on the effect of ECT using the Montgomery-Åsberg Depression Rating Scale (MADRS). We further analyzed the influence of the ADs Bupropion, Venlafaxine, and Sertraline or no AD and the influence of augmentation with Aripiprazole or Quetiapine or Olanzapine. Psychotropic medication did not have an impact on antidepressant efficacy of ECT as measured with the MADRS scores. In addition, the comparison between the antidepressant or antipsychotic medications themselves did not show any significant difference. However, we found a significantly different seizure duration depending on the antidepressant substance that patients received during ECT ( = .008). ECT treatment itself led to a highly significant reduction of 13.3 points in the MADRS ( &lt;.001). Taken together, our study underlines that concomitant psychotropic medication while doing electroconvulsive therapy does not bare the risk of prolonged seizure duration or does it reduce the effectiveness of ECT. To the best of our knowledge, this study is the first to examine the effect of treatment with antidepressants in combination with antipsychotics while doing ECT. In light of our results, this combination therapy is safe and effective. Bearing in mind the delay in onset of antidepressant action of medication and the importance of antidepressant medication for relapse prevention, this study further supports the recommendation that psychotropic medication should be given in adjunction to ECT.</abstract><cop>Switzerland</cop><pub>Frontiers Media S.A</pub><pmid>38563025</pmid><doi>10.3389/fpsyt.2024.1341508</doi><tpages>1</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1664-0640
ispartof Frontiers in psychiatry, 2024-03, Vol.15, p.1341508-1341508
issn 1664-0640
1664-0640
language eng
recordid cdi_doaj_primary_oai_doaj_org_article_6d20a0d18f4244b89a360843ecfa920d
source Open Access: PubMed Central
subjects antidepressants
antipsychotics
ECT
electroconvulsive therapy
Psychiatry
seizure duration
title The influence of concomitant antidepressant and antipsychotic medication on antidepressant effect and seizure duration of electroconvulsive therapy
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-27T15%3A13%3A22IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20influence%20of%20concomitant%20antidepressant%20and%20antipsychotic%20medication%20on%20antidepressant%20effect%20and%20seizure%20duration%20of%20electroconvulsive%20therapy&rft.jtitle=Frontiers%20in%20psychiatry&rft.au=Mohamad,%20Sara&rft.date=2024-03-18&rft.volume=15&rft.spage=1341508&rft.epage=1341508&rft.pages=1341508-1341508&rft.issn=1664-0640&rft.eissn=1664-0640&rft_id=info:doi/10.3389/fpsyt.2024.1341508&rft_dat=%3Cproquest_doaj_%3E3031130780%3C/proquest_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c420t-99007768644a260fd8456d9c20321fc9da34be7e4f00ada1fb719db815840f6c3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=3031130780&rft_id=info:pmid/38563025&rfr_iscdi=true